Palifermin and burning sensation 
Palifermin and burning sensation Patient Reports February 12, 2012
Palifermin Side Effects Report #5045778-1
Palifermin side effect was reported by a Physician from UNITED STATES on June 27, 2006. Male patient, weighting 202.2 lb, was diagnosed with stomatitis and was treated with Palifermin. After drug was administered, patient experienced the following side effects: burning sensation, hypersensitivity. Palifermin dosage: unknown. During the same period patient was treated with VICODIN, LORAZEPAM, VIBRAMYCIN, SUDAFED, EQUATE, LORTAB. Patient recovered.
Palifermin Side Effects Report #5067135-4
Palifermin side effect was reported by a Physician from BELGIUM on July 19, 2006. Female patient, weighting 165.3 lb, was diagnosed with peripheral blood stem cell apheresis and was treated with Palifermin. After drug was administered, patient experienced the following side effects: burning sensation, capillary leak syndrome, fluid retention, hypersensitivity, rash
, stomatitis. Palifermin dosage: unknown. During the same period patient was treated with CARMUSTINE, ETOPOSIDE, CYTARABINE, METHOTREXATE. Patient recovered.Palifermin Side Effects Report #5122698-5
Palifermin side effect was reported by a Physician from BELGIUM on July 19, 2006. Female patient, weighting 165.3 lb, was diagnosed with peripheral blood stem cell apheresis and was treated with Palifermin. After drug was administered, patient experienced the following side effects: bacteraemia, burning sensation, capillary leak syndrome, febrile neutropenia, fluid retention, hypersensitivity, mucosal inflammation, rash
, stomatitis. Palifermin dosage: unknown. During the same period patient was treated with CARMUSTINE, ETOPOSIDE, CYTARABINE, METHOTREXATE, MELPHALAN, CISPLATIN, NEUPOGEN. Patient was hospitalized. Patient recovered.Palifermin Side Effects Report #5170386-1
Palifermin side effect was reported by a Physician from BELGIUM on July 19, 2006. Female patient, weighting 165.3 lb, was diagnosed with peripheral blood stem cell apheresis and was treated with Palifermin. After drug was administered, patient experienced the following side effects: bacteraemia, burning sensation, capillary leak syndrome, febrile neutropenia, fluid retention, hypersensitivity, mucosal inflammation, rash
, stomatitis. Palifermin dosage: unknown. During the same period patient was treated with CARMUSTINE, ETOPOSIDE, CYTARABINE, METHOTREXATE, MELPHALAN, CISPLATIN, NEUPOGEN. Patient was hospitalized. Patient recovered.